close
MENU
Hot Topic DEALMAKERS
Hot Topic DEALMAKERS
Investment
3 mins to read

Asia Pacific Healthcare Group buys biotech company Rako Science

Rako Science will operate its Covid saliva testing as a stand-alone business.

APHG is the country's largest laboratory provider.

Asia Pacific Healthcare Group (APHG) has bought Kiwi biotech company Rako Science which established Covid-19 saliva surveillance testing in New Zealand.

The deal, for an undisclosed sum, will see Rako Science operate as a stand-alone company and continue to offer its saliva-based PCR test to the

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Wed, 26 Oct 2022
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Asia Pacific Healthcare Group buys biotech company Rako Science
Investment,
96316
true